| P50 | author | Volkan Solmaz | Q64857219 |
| P2093 | author name string | Durdane Aksoy | |
| | Fikret Erdemir | |
| | Serhat Tanik | |
| | Nermin Tanik | |
| | Fatih Firat | |
| | Sebahattin Albayrak | |
| | Meral Oran Demir | |
| | Yusuf Gencden | |
| P2860 | cites work | Which anticholinergic drug for overactive bladder symptoms in adults | Q24246651 |
| | An Inventory for Measuring Depression | Q26778503 |
| | How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study | Q28202479 |
| | Pharmacological profile of antidepressants and related compounds at human monoamine transporters | Q28267324 |
| | A review of the quality-of-life aspects of urinary urge incontinence | Q33571842 |
| | Role of 5-HT1A receptors in control of lower urinary tract function in anesthetized rats | Q33727827 |
| | Treatment of the overactive bladder: possible central nervous system drug targets | Q34635396 |
| | Pharmacological agents used for the treatment of stress urinary incontinence in women | Q35574096 |
| | New pharmacologic targets for the treatment of the overactive bladder: an update | Q35687975 |
| | Use of antidepressant medications during pregnancy: a multisite study | Q36955493 |
| | Anticholinergics for overactive bladder therapy: central nervous system effects. | Q37954372 |
| | Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. | Q41677321 |
| | Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle | Q41808678 |
| | Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. | Q43494327 |
| | National community prevalence of overactive bladder in the United States stratified by sex and age. | Q43838020 |
| | Lower urinary tract symptoms and depression | Q43872116 |
| | Duloxetine versus placebo in the treatment of stress urinary incontinence | Q44062087 |
| | Selective serotonin reuptake inhibitor-induced urinary incontinence | Q44077576 |
| | Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence | Q44763401 |
| | Nocturia, depression and antidepressant medication | Q46407827 |
| | Venlafaxine-induced urinary incontinence resolved after switching to sertraline | Q46766264 |
| | Association between cigarette smoking and depressive symptoms among military medical students in Turkey. | Q51974066 |
| | Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. | Q53248115 |
| | The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. | Q53317478 |
| | Algorithms for the treatment of subtypes of unipolar major depression | Q57739564 |
| | Serotonergic antidepressants and urinary incontinence | Q73370426 |
| | PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES | Q76826495 |
| | Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice | Q77744745 |
| P433 | issue | 9 | |
| P304 | page(s) | 1479-1484 | |
| P577 | publication date | 2015-08-06 | |
| P1433 | published in | International Urology and Nephrology | Q15763616 |
| P1476 | title | Assessment of overactive bladder in women antidepressant users | |
| P478 | volume | 47 | |